Park National Corp OH boosted its holdings in shares of Clorox Co (NYSE:CLX) by 18.1% in the third quarter, according to its most recent filing with the SEC. The firm owned 5,222 shares of the company’s stock after acquiring an additional 800 shares during the period. Park National Corp OH’s holdings in Clorox were worth $1,098,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Tiemann Investment Advisors LLC grew its position in shares of Clorox by 11.8% during the 2nd quarter. Tiemann Investment Advisors LLC now owns 1,429 shares of the company’s stock worth $314,000 after buying an additional 151 shares during the period. Cigna Investments Inc. New boosted its position in shares of Clorox by 16.1% during the second quarter. Cigna Investments Inc. New now owns 4,075 shares of the company’s stock worth $894,000 after purchasing an additional 566 shares in the last quarter. Sawtooth Solutions LLC grew its holdings in shares of Clorox by 67.8% in the 2nd quarter. Sawtooth Solutions LLC now owns 3,580 shares of the company’s stock valued at $785,000 after buying an additional 1,446 shares during the period. Cornerstone Advisors LLC bought a new stake in shares of Clorox in the 2nd quarter valued at $1,316,000. Finally, CWA Asset Management Group LLC raised its stake in Clorox by 4.4% during the 1st quarter. CWA Asset Management Group LLC now owns 1,367 shares of the company’s stock worth $237,000 after buying an additional 58 shares during the period. 79.18% of the stock is owned by hedge funds and other institutional investors.
CLX stock opened at $211.65 on Friday. Clorox Co has a twelve month low of $144.12 and a twelve month high of $239.87. The company has a quick ratio of 1.10, a current ratio of 1.42 and a debt-to-equity ratio of 3.06. The business has a 50 day moving average price of $217.02 and a two-hundred day moving average price of $207.94. The company has a market cap of $26.48 billion, a price-to-earnings ratio of 28.80, a P/E/G ratio of 3.82 and a beta of 0.27.
Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, August 3rd. The company reported $2.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.00 by $0.41. Clorox had a net margin of 13.97% and a return on equity of 138.70%. The firm had revenue of $1.98 billion for the quarter, compared to analyst estimates of $1.86 billion. During the same period in the prior year, the firm posted $1.88 earnings per share. The company’s quarterly revenue was up 21.9% compared to the same quarter last year. On average, equities research analysts anticipate that Clorox Co will post 7.75 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 20th. Shareholders of record on Wednesday, November 4th will be paid a $1.11 dividend. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $4.44 annualized dividend and a yield of 2.10%. Clorox’s dividend payout ratio is 60.33%.
In other news, SVP Diego J. Barral sold 10,041 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $235.59, for a total value of $2,365,559.19. Following the transaction, the senior vice president now owns 13,931 shares of the company’s stock, valued at $3,282,004.29. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Andrew J. Mowery sold 12,932 shares of Clorox stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $235.97, for a total value of $3,051,564.04. Following the sale, the senior vice president now directly owns 18,456 shares of the company’s stock, valued at $4,355,062.32. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.
CLX has been the subject of several recent analyst reports. DA Davidson lowered their price target on Clorox from $269.00 to $263.00 and set a “buy” rating for the company in a report on Wednesday. Citigroup increased their target price on Clorox from $206.00 to $246.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 4th. Credit Suisse Group lifted their price target on shares of Clorox from $185.00 to $200.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Zacks Investment Research downgraded shares of Clorox from a “buy” rating to a “hold” rating and set a $249.00 price objective for the company. in a research report on Thursday, August 6th. Finally, Deutsche Bank raised their price objective on shares of Clorox from $174.00 to $223.00 and gave the stock a “hold” rating in a report on Monday, July 27th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. Clorox presently has a consensus rating of “Hold” and an average price target of $202.50.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Quiet Period
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.